Product correctly added to cart.

discount label
H-SNFVFAGI-OH
View 3D

Biosynth logo

H-SNFVFAGI-OH

Ref. 3D-PP46186

1mg
202.00 €
10mg
234.00 €
100mg
412.00 €
Estimated delivery in United States, on Friday 27 Dec 2024

Product Information

Name:
H-SNFVFAGI-OH
Synonyms:
  • NH2-Ser-Asn-Phe-Val-Phe-Ala-Gly-Ile-OH
Description:

Peptide H-SNFVFAGI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SNFVFAGI-OH include the following: Dead box for the living UAO Heinlein - The Journal of Pathology: A Journal of the , 1998 - Wiley Online Libraryhttps://pathsocjournals.onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1096-9896(199804)184:4%3C345::AID-PATH1243%3E3.0.CO;2-6 Rejection of immunogenic tumor clones is limited by clonal fraction RS Gejman , AY Chang , HF Jones, K DiKun, AA Hakimi - Elife, 2018 - elifesciences.orghttps://elifesciences.org/articles/41090 The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68 P Dubey , RC Hendrickson , SC Meredith - The Journal of , 1997 - rupress.orghttps://rupress.org/jem/article-abstract/185/4/695/7111 Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells MT Spiotto, H Schreiber - Cancer immunity, 2005 - AACRhttps://aacrjournals.org/cancerimmun/article-abstract/5/1/8/472010 Eradication of large solid tumors by gene therapy with a T-cell receptor targeting a single cancer-specific point mutation M Leisegang, B Engels, K Schreiber, PY Yew - Clinical Cancer , 2016 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/22/11/2734/79305 Tracking the common ancestry of antigenically distinct cancer variants K Schreiber, TH Wu, WM Kast , H Schreiber - Clinical cancer research, 2001 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/7/3/871s/200034 Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer DC Binder, B Engels, A Arina, P Yu, JM Slauch - Cancer immunology , 2013 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/1/2/123/466730

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-PP46186 H-SNFVFAGI-OH

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".